Back to Agenda
Reflections on the New Legislation; is it meeting the objectives?
Session Chair(s)
Michael Richardson, MD, FFPM, FRCP
Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
Speaker(s)
Are Patients Better Protected? – An industry view
Thomas Lönngren, PharmD
NDA Group, Sweden
Strategic Advisor
Was the Pain Worth the Gain?
Barry Arnold, MD
AstraZeneca, United Kingdom
EU Qualified Person for Pharmacovigilance
And what do patients think?
David Haerry
EUPATI Foundation,European AIDS Treatment Group, Belgium
Co-Chair Advisory Committee
Have an account?